Unmet Needs and Future Research Focus for Endometrial Cancer

Panelists discuss how significant unmet needs persist in the treatment of endometrial cancer despite recent advances. They identify challenges such as improving outcomes in mismatch repair–proficient/microsatellite-stable disease, managing treatment resistance, and expanding therapeutic access for diverse populations. The discussion also highlights disparities in diagnosis and care delivery that continue to impact prognosis and quality of life.

The conversation turns toward the need for more personalized approaches, including better integration of molecular profiling, novel combinations, and real-world data to guide clinical practice. Panelists stress the importance of collaboration between researchers, clinicians, and policymakers to close existing gaps and ensure equitable innovation.

In closing, they emphasize that the future of endometrial cancer care will rely on maintaining momentum in translational research and prioritizing patient-centered strategies. Continued commitment to addressing these unmet needs will be critical for advancing survival and quality of life across all patient groups.